Engraftment of human glioblastoma cells in immunocompetent rats through acquired immunosuppression

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Huszthy, Peter C ^a,b   Sakariassen, Per Ø ^a   Espedal, Heidi ^a   Brokstad, Karl A ^a   Bjerkvig, Rolf ^a,c   Miletic, Hrvoje ^a,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; CXCL10 PROTEIN, RAT; CXCL12 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CANCER TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LEUKOCYTE; LEUKOCYTE MIGRATION; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; RAT; TUMOR ENGRAFTMENT; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BLOOD; BRAIN TUMOR; DISEASE MODEL; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MULTICELLULAR SPHEROID; NUDE RAT; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; TUMOR CELL CULTURE;

ANIMALS; BRAIN NEOPLASMS; CHEMOKINE CXCL10; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; FEMALE; GLIOBLASTOMA; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOCOMPETENCE; INTERLEUKIN-18; INTERLEUKIN-1BETA; MALE; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; RATS; RATS, NUDE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84942885060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136089     Document Type: Article

References (42)

1. Fack F, Espedal H, Keunen O, Golebiewska A, Obad N, Harter PN, et al. Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta neuropathologica. 2014. doi: 10.1007/s00401-014-1352-5 PMID: 25322816.
2. Huszthy PC, Giroglou T, Tsinkalovsky O, Euskirchen P, Skaftnesmo KO, Bjerkvig R, et al. Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy. PloS one. 2009;4(7):e6314. doi: 10.1371/journal.pone.0006314 PMID: 19617915; PubMed Central PMCID: PMC2707627.
3. Huszthy PC, Svendsen A, Wilson JM, Kotin RM, Lonning PE, Bjerkvig R, et al. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts. Human gene therapy. 2005;16(3):381-92. doi: 10.1089/hum.2005.16.381 PMID: 15812233.
4. Najbauer J, Huszthy PC, Barish ME, Garcia E, Metz MZ, Myers SM, et al. Cellular host responses to gliomas. PloS one. 2012;7(4):e35150. doi: 10.1371/journal.pone.0035150 PMID: 22539956; PubMed Central PMCID: PMC3335155.
5. Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, et al. Angiogenesisindependent tumor growth mediated by stem-like cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(44):16466-71. doi: 10.1073/pnas. 0607668103 PMID: 17056721; PubMed Central PMCID: PMC1618812.
6. Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, et al. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta neuropathologica. 2013;125(5):683-98. doi: 10.1007/s00401-013-1101-1 PMID: 23429996; PubMed Central PMCID: PMC3631314.
7. Wang J, Miletic H, Sakariassen PO, Huszthy PC, Jacobsen H, Brekka N, et al. A reproducible brain tumour model established from human glioblastoma biopsies. BMC cancer. 2009;9:465. doi: 10.1186/1471-2407-9-465 PMID: 20040089; PubMed Central PMCID: PMC2810304.
8. Huszthy PC, Daphu I, Niclou SP, Stieber D, Nigro JM, Sakariassen PO, et al. In vivo models of primary brain tumors: pitfalls and perspectives. Neuro-oncology. 2012;14(8):979-93. doi: 10.1093/neuonc/nos135 PMID: 22679124; PubMed Central PMCID: PMC3408261.
9. De Witt Hamer PC, Van Tilborg AA, Eijk PP, Sminia P, Troost D, Van Noorden CJ, et al. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene. 2008;27(14):2091-6. doi: 10.1038/sj.onc.1210850 PMID: 17934519.
10. Talasila KM, Brekka N, Mangseth K, Stieber D, Evensen L, Rosland GV, et al. Tumor versus stromal cells in culture-survival of the fittest? PloS one. 2013;8(12):e81183. doi: 10.1371/journal.pone. 0081183 PMID: 24349039; PubMed Central PMCID: PMC3857854.
11. Stromblad LG, Brun A, Salford LG, Stenevi U. A model for xenotransplantation of human malignant astrocytomas into the brain of normal adult rats. Acta neurochirurgica. 1982;65(3-4):217-26. PMID: 6295074.
12. Greene HS. The transplantation of human brain tumors to the brains of laboratory animals. Cancer research. 1953;13(6):422-6. PMID: 13051754.
13. Krementz ET, Greene HS. Heterologous transplantation of human neural tumors. Cancer. 1953;6(1):100-10. PMID: 13009658.
14. Leveque X, Cozzi E, Naveilhan P, Neveu I. Intracerebral xenotransplantation: recent findings and perspectives for local immunosuppression. Current opinion in organ transplantation. 2011;16(2):190-4. doi: 10.1097/MOT.0b013e32834494b5 PMID: 21415822.
15. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO. Multicellular tumor spheroids from human gliomas maintained in organ culture. Journal of neurosurgery. 1990;72(3):463-75. doi: 10.3171/jns.1990.72.3. 0463 PMID: 2406382.
16. Rolstad B. The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses? Immunological reviews. 2001;184:136-44. PMID: 11918682.
17. Ekdahl CT. Microglial activation-tuning and pruning adult neurogenesis. Frontiers in pharmacology. 2012;3:41. doi: 10.3389/fphar.2012.00041 PMID: 22408626; PubMed Central PMCID: PMC3297835.
18. Utans U, Arceci RJ, Yamashita Y, Russell ME. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. The Journal of clinical investigation. 1995;95(6):2954-62. doi: 10.1172/JCI118003 PMID: 7769138; PubMed Central PMCID: PMC295984.
19. Gabrusiewicz K, Ellert-Miklaszewska A, Lipko M, Sielska M, Frankowska M, Kaminska B. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PloS one. 2011;6(8):e23902. doi: 10.1371/journal.pone.0023902 PMID: 21901144; PubMed Central PMCID: PMC3162015.
20. Xu J, Wang H, Ding K, Lu X, Li T, Wang J, et al. Inhibition of cathepsin S produces neuroprotective effects after traumatic brain injury in mice. Mediators of inflammation. 2013;2013:187873. doi: 10. 1155/2013/187873 PMID: 24282339; PubMed Central PMCID: PMC3824312.
21. Kirschke H, Wiederanders B, Bromme D, Rinne A. Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. The Biochemical journal. 1989;264(2):467-73. PMID: 2690828; PubMed Central PMCID: PMC1133603.
22. Revoltella RP, Menicagli M, Campani D. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas. Cytokine. 2012;57(3):347-59. doi: 10.1016/j.cyto. 2011.11.016 PMID: 22200506.
23. Marshall SE, Cobbold SP, Davies JD, Martin GM, Phillips JM, Waldmann H. Tolerance and suppression in a primed immune system. Transplantation. 1996;62(11):1614-21. PMID: 8970617.
24. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity. 2001;14(4):437-46. PMID: 11336689.
25. Barker RA, Widner H. Immune problems in central nervous system cell therapy. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics. 2004;1(4):472-81. doi: 10.1602/neurorx.1. 4.472 PMID: 15717048; PubMed Central PMCID: PMC534953.
26. Melchior B, Remy S, Nerriere-Daguin V, Heslan JM, Soulillou JP, Brachet P. Temporal analysis of cytokine gene expression during infiltration of porcine neuronal grafts implanted into the rat brain. Journal of neuroscience research. 2002;68(3):284-92. doi: 10.1002/jnr.10216 PMID: 12111858.
27. Gonzalez H, Elgueta D, Montoya A, Pacheco R. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. Journal of neuroimmunology. 2014;274(1-2):1-13. doi: 10.1016/j.jneuroim.2014.07.012 PMID: 25091432.
28. Merrill JE, Murphy SP. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain, behavior, and immunity. 1997;11(4):245-63. doi: 10.1006/brbi.1997.0496 PMID: 9512813.
29. Tiemessen MM, Kunzmann S, Schmidt-Weber CB, Garssen J, Bruijnzeel-Koomen CA, Knol EF, et al. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response. International immunology. 2003;15(12):1495-504. PMID: 14645158.
30. Roberts AB. Molecular and cell biology of TGF-beta. Mineral and electrolyte metabolism. 1998;24(2-3):111-9. PMID: 9525693.
31. Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, et al. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2004;24(39):8500-9. doi: 10.1523/JNEUROSCI.2451-04.2004 PMID: 15456824.
32. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. Journal of virology. 2005;79(17):11457-66. doi: 10.1128/JVI.79.17.11457-11466.2005 PMID: 16103196; PubMed Central PMCID: PMC1193600.
33. McCandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, et al. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. The American journal of pathology. 2008;172(3):799-808. doi: 10.2353/ajpath.2008.070918 PMID: 18276777; PubMed Central PMCID: PMC2258272.
34. Chang CY, Li MC, Liao SL, Huang YL, Shen CC, Pan HC. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2005;12(8):930-3. doi: 10.1016/j.jocn. 2004.11.017 PMID: 16326273.
35. Weissenberger J, Loeffler S, Kappeler A, Kopf M, Lukes A, Afanasieva TA, et al. IL-6 is required for glioma development in a mouse model. Oncogene. 2004;23(19):3308-16. doi: 10.1038/sj.onc.1207455 PMID: 15064729.
36. McLoughlin RM, Jenkins BJ, Grail D, Williams AS, Fielding CA, Parker CR, et al. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(27):9589-94. doi: 10.1073/pnas.0501794102 PMID: 15976028; PubMed Central PMCID: PMC1172246.
37. Yeung YT, McDonald KL, Grewal T, Munoz L. Interleukins in glioblastoma pathophysiology: implications for therapy. British journal of pharmacology. 2013;168(3):591-606. doi: 10.1111/bph.12008 PMID: 23062197; PubMed Central PMCID: PMC3579281.
38. Gimbrone MA Jr, Obin MS, Brock AF, Luis EA, Hass PE, Hebert CA, et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science. 1989;246(4937):1601-3. PMID: 2688092.
39. Souza DG, Bertini R, Vieira AT, Cunha FQ, Poole S, Allegretti M, et al. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. British journal of pharmacology. 2004;143(1):132-42. doi: 10.1038/sj.bjp. 0705862 PMID: 15302676; PubMed Central PMCID: PMC1575259.
40. Bedke J, Nelson PJ, Kiss E, Muenchmeier N, Rek A, Behnes CL, et al. A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage. Molecular immunology. 2010;47(5):1047-57. doi: 10.1016/j.molimm.2009.11.012 PMID: 20004976.
41. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444(7120):761-5. doi: 10.1038/nature05349 PMID: 17151667.
42. Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB journal: official publication of the Federation of American Societies for Experimental Biology.. 2011;25(5):1653-63. doi: 10.1096/fj.10-176917 PMID: 21282204; PubMed Central PMCID: PMC3079306.